Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROSUVASTATIN Cause Electrocardiogram st segment elevation? 33 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Electrocardiogram st segment elevation have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.1% of all adverse event reports for ROSUVASTATIN.

33
Reports of Electrocardiogram st segment elevation with ROSUVASTATIN
0.1%
of all ROSUVASTATIN reports
2
Deaths
28
Hospitalizations

How Dangerous Is Electrocardiogram st segment elevation From ROSUVASTATIN?

Of the 33 reports, 2 (6.1%) resulted in death, 28 (84.8%) required hospitalization.

Is Electrocardiogram st segment elevation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 33 reports have been filed with the FAERS database.

What Other Side Effects Does ROSUVASTATIN Cause?

Myalgia (3,958) Dyspnoea (2,832) Pain (2,758) Drug ineffective (2,347) Fatigue (2,208) Rhabdomyolysis (2,173) Arthralgia (1,879) Asthma (1,843) Muscle spasms (1,843) Pain in extremity (1,686)

What Other Drugs Cause Electrocardiogram st segment elevation?

PROPOFOL (96) FLUOROURACIL (91) ASPIRIN (78) OXALIPLATIN (73) CAPECITABINE (71) CLOZAPINE (69) EPINEPHRINE (55) QUETIAPINE (51) CLOPIDOGREL BISULFATE (49) ALBUTEROL (45)

Which ROSUVASTATIN Alternatives Have Lower Electrocardiogram st segment elevation Risk?

ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN ROSUVASTATIN vs ROTIGOTINE ROSUVASTATIN vs ROXADUSTAT ROSUVASTATIN vs ROXICODONE ROSUVASTATIN vs ROXITHROMYCIN

Related Pages

ROSUVASTATIN Full Profile All Electrocardiogram st segment elevation Reports All Drugs Causing Electrocardiogram st segment elevation ROSUVASTATIN Demographics